Integra LifeSciences Schedules Conference Call for Wednesday, February 28 to Discuss Fourth Quarter 2006 Financial Results and Update Forward-Looking Financial Guidance
The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward-looking information may be discussed in a question and answer session following the call.
Access to the live call is available by dialing 913-312-1235 or through a webcast via a link provided on the Investor Relations homepage of Integra's website at www.Integra-LS.com. Access to a replay is available through March 14, 2007 by dialing 719-457-0820 (PIN 4583668) or through the webcast.
Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets implants for surgery and a broad line of medical and surgical instruments. The primary applications for our products are neurosurgery, extremity reconstruction and orthopedics. Integra is a world leader in regenerative medicine. Our products provide cost effective solutions that improve the quality of life for patients. Our corporate headquarters are in Plainsboro, New Jersey, and we have manufacturing and research facilities located throughout the world. Please visit our website at (http://www.Integra-LS.com).
This news release was distributed by PrimeNewswire, www.primenewswire.com
SOURCE: Integra LifeSciences Holdings Corp.
Integra LifeSciences Holdings Corporation
Maureen Bellantoni, Executive Vice President and
Chief Financial Officer
(609) 936-6822
Maureen.Bellantoni@Integra-LS.com
John Bostjancic, Vice President, Corporate Development
and Investor Relations
(609) 936-2239
jbostjancic@Integra-LS.com